| TACE Combined With Sorafenib and Tislelizumab for Advanced HCC (NCT04599777) | Second Affiliated Hospital of Guangzhou Medical University | 2020-10-01 |
| A Clinical Study on the Prevention of Mild to Moderate Intermittent Asthma With Chinese Medicine Weiyang Yuping Fang (NCT04522726) | Shanghai University of Traditional Chinese Medicine | 2020-10-01 |
| Dose-ranging Study of SKF7™ for Obesity (NCT04557267) | Indonesia University | 2020-09-30 |
| Study of ATI-1777 in Adult Patients With Moderate or Severe Atopic Dermatitis (NCT04598269) | Aclaris Therapeutics, Inc. | 2020-09-30 |
| MERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS) (NCT04579666) | Apellis Pharmaceuticals, Inc. | 2020-09-30 |
| Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study (NCT04175431) | University of Washington | 2020-09-30 |
| Clinical Evaluation of New Treatment Strategy of Mucous Membrane Pemphigoid Using Large Dose of Prednisolone Plus Intra-lesional of Triamcinolone Acetonide Followed by Combination of Mycophenolate Mofetil, Dapsone and Low Dose Prednisolone (NCT04744623) | Tanta University | 2020-09-30 |
| A Study To Evaluate The Safety And Efficacy Of PF-06826647 In Participants With Moderate To Severe Ulcerative Colitis (NCT04209556) | Pfizer | 2020-09-30 |
| Less Frequent IV Dosing & Tumor Microenvironment (TME) Study of Nemvaleukin Alfa (ALKS 4230) Monotherapy and in Combination With Pembrolizumab (ARTISTRY-3) (NCT04592653) | Mural Oncology, Inc | 2020-09-30 |
| Safety Evaluation of ART352-L in Subjects Undergoing Posterolateral Spinal Fusion (NCT04378543) | Ankasa Regenerative Therapeutics, Inc. | 2020-09-30 |
| FOLFOX + Immunotherapy With Intrahepatic Oxaliplatin for Patients With Metastatic Colorectal Cancer (NCT04430985) | Dorte Nielsen | 2020-09-30 |
| Durvalumab Combined With Chemotherapy and Stereotactic Body Radiotherapy (SBRT) in Patients With Oligometastatic Non-small Cell Lung Cancer (NSCLC) (NCT04255836) | Zhejiang Cancer Hospital | 2020-09-30 |
| Open-Label Study of Parsaclisib, in Japanese Participants With Relapsed or Refractory Follicular Lymphoma (CITADEL-213) (NCT04434937) | Incyte Biosciences Japan GK | 2020-09-30 |
| Long-term Clinical Study of CN128 in Thalassemia Patients (NCT04614779) | Hangzhou Zede Pharma-Tech Co., Ltd. | 2020-09-30 |
| A Study of the Safety and Efficacy of SP-624 in the Treatment of Adults With Major Depressive Disorder (NCT04479852) | Sirtsei Pharmaceuticals, Inc. | 2020-09-30 |
| GALLANT: Metronomic Gemcitabine, Doxorubicin, Docetaxel and Nivolumab for Advanced Sarcoma (NCT04535713) | Sarcoma Oncology Research Center, LLC | 2020-09-30 |
| Biomarker Effects of ALZ-801 in APOE4 Carriers With Early Alzheimer's Disease (NCT04693520) | Alzheon Inc. | 2020-09-30 |
| Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes (NCT04531631) | Chinese University of Hong Kong | 2020-09-30 |
| Previfenon® as Chemoprophylaxis of COVID-19 in Health Workers (NCT04446065) | MELISA Institute Genomics & Proteomics Research SpA | 2020-09-30 |
| A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participants With Non-Alcoholic Steatohepatitis (NCT04171765) | Genentech, Inc. | 2020-09-30 |
| P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19 (NCT04410510) | Hospital Universitario San Ignacio | 2020-09-30 |
| Ruxolitinib Cream in the Treatment of Cutaneous Necrobiosis Lipoidica (NCT04492618) | Aaron R. Mangold | 2020-09-29 |
| 2018-0674 - IL-7 for T-Cell Recovery Post Haplo and CB Transplant - Phase I/II (NCT03941769) | M.D. Anderson Cancer Center | 2020-09-29 |
| Polyethylene Glycol and Intestinal Inflammation in Cystic Fibrosis (NCT04458129) | University Hospital, Bordeaux | 2020-09-29 |
| CAR T-cells Against CD30 (HSP-CAR30) for Relapsed/ Refractory Hodgkin and T-cell Lymphoma. (NCT04653649) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2020-09-29 |
| ABC-lung: Atezolizumab, Bevacizumab and Chemotherapy in EGFR-mutant Non-small Cell Lung Carcinoma (NCT04245085) | ETOP IBCSG Partners Foundation | 2020-09-29 |
| Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors (NCT04383210) | Elevation Oncology | 2020-09-29 |
| ALI Post Radiation Therapy in Patients With Lung and Esophageal Canter (NCT04668833) | M.D. Anderson Cancer Center | 2020-09-29 |
| Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma (NCT04577014) | Memorial Sloan Kettering Cancer Center | 2020-09-29 |
| Evaluation of Lasofoxifene Combined With Abemaciclib in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation (NCT04432454) | Sermonix Pharmaceuticals Inc. | 2020-09-29 |
| Pembrolizumab + Capecitabine／Oxaliplatin (CapeOx) -HER2 Nagative and Pembrolizumab + Trastuzumab + Cisplatin/Capecitabine HER2 Positive (NCT04249739) | Samsung Medical Center | 2020-09-29 |
| Dose-Response Study of MR-107A-01 in The Treatment of Post-Surgical Dental Pain (NCT04571515) | Mylan Inc. | 2020-09-29 |
| A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV) (NCT04422912) | Cabaletta Bio | 2020-09-29 |
| A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer (NCT04574284) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2020-09-29 |
| Effects of Tralokinumab Treatment of Atopic Dermatitis on Skin Barrier Function (NCT04556461) | Prof. Dr. Stephan Weidinger | 2020-09-28 |
| A Study Comparing Savolitinib Plus Osimertinib vs Savolitinib Plus Placebo in Patients With EGFRm+ and MET Amplified Advanced NSCLC (NCT04606771) | AstraZeneca | 2020-09-28 |
| The Safety and Efficacy of Istaroxime for Pre-Cardiogenic Shock (NCT04325035) | Windtree Therapeutics | 2020-09-28 |
| Fruquintinib and Raltitrexed Versus Fruquintinib Monotherapy in Advanced Colorectal Cancer (NCT04582981) | Fudan University | 2020-09-28 |
| A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70) (NCT04516291) | Pfizer | 2020-09-28 |
| Testing Less Intensive Radiation With Chemotherapy to Treat Low-risk Patients With HPV-positive Oropharyngeal Cancer (NCT04444869) | University of Missouri-Columbia | 2020-09-28 |
| A Study to Evaluate the Efficacy and Safety of Toripalimab Injection in the Treatment of Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Who Have Failed at Least Two Prior Lines of Therapy and Are Positive Specific Markers (NCT04603040) | Shanghai Junshi Bioscience Co., Ltd. | 2020-09-28 |
| Phase II Study Evaluating the Efficacy and Safety of KX-826 (NCT05940506) | Suzhou Kintor Pharmaceutical Inc, | 2020-09-28 |
| The Role of TCM on ERAS of Rectal Cancer Patients (NCT04749381) | Peking University Cancer Hospital & Institute | 2020-09-28 |
| TDCS to Reduce Craving in Cocaine Addiction- Phase 2 Study (NCT04994821) | Soterix Medical | 2020-09-28 |
| Study of Lisaftoclax (APG-2575) Single Agent and Combination With Therapy in Patients Relapsed/Refractory AML (NCT04501120) | Ascentage Pharma Group Inc. | 2020-09-28 |
| Irinotecan Hydrochloride Liposome Injection (LY01610) For Small Cell Lung Cancer (NCT04381910) | Luye Pharma Group Ltd. | 2020-09-28 |
| ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease (NCT04488419) | LeonaBio | 2020-09-28 |
| Safety & Efficacy of Encapsulated Allogeneic FVIII Cell Therapy in Haemophilia A (NCT04541628) | Eli Lilly and Company | 2020-09-28 |
| HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005 (NCT04566445) | Gyroscope Therapeutics Limited | 2020-09-28 |
| A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy (NCT04378075) | PTC Therapeutics | 2020-09-28 |
| Melanoma Vaccine Against Neoantigen and Shared Antigens by CD40 Activation and TLR Agonists In Patients With Melanoma (Including Ocular Melanoma) (NCT04364230) | Craig L Slingluff, Jr | 2020-09-28 |
| A Study to Assess the Safety, Tolerability, and Effect on Disease Progression of BIIB105 in Participants With Amyotrophic Lateral Sclerosis (ALS) and Participants With the ALS Ataxin-2 (ATXN2) Genetic Mutation (NCT04494256) | Biogen | 2020-09-28 |
| Neuroimaging Guided and Robot-assisted rTMS for Suicidal Ideation of Depression (NCT04653337) | Xijing Hospital | 2020-09-28 |
| A Phase I/II Clinical Trial of ICP-723 in the Treatment of Advanced Solid Tumors (NCT04685226) | Beijing InnoCare Pharma Tech Co., Ltd. | 2020-09-27 |
| A Study to Evaluate LTI-01 in Patients With Infected, Non-draining Pleural Effusions (NCT04159831) | Rein Therapeutics | 2020-09-26 |
| A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER) (NCT04333706) | University of Southern California | 2020-09-26 |
| Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs) (NCT04375228) | Columbia University | 2020-09-25 |
| Safety and Efficacy of NTX-001 Compared to SOC in Acute Single Peripheral Nerve Injuries (NCT04572906) | Neuraptive Therapeutics Inc. | 2020-09-25 |
| Tenecteplase in Patients With COVID-19 (NCT04505592) | Hooman Poor | 2020-09-25 |
| A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD22 for Relapsed/Refractory Leukemia or Lymphoma (NCT04571138) | Seattle Children's Hospital | 2020-09-25 |
| Camrelizumab With Chemotherapy in Adults With Medically Inoperable Early Stage NSCLC (NCT04530227) | Tianjin Medical University Cancer Institute and Hospital | 2020-09-25 |
| Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Brain Tumors (NCT04738162) | Universität Münster | 2020-09-25 |
| A Study Evaluating the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia (NCT04623021) | Chong Kun Dang Pharmaceutical | 2020-09-25 |
| Study of HX008 for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer (NCT04738630) | Taizhou Hanzhong biomedical co. LTD | 2020-09-25 |
| Effect of Ultrasound-guided Transversus Abdominis Plane Block After Laparoscopic Bariatric Surgery (NCT05016180) | Tianjin Medical University General Hospital | 2020-09-25 |
| HX008 Plus Chemotherapy VS Pembrolizumab Plus Chemotherapy As the First-line Treatment in Participants With Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NCT04750083) | Taizhou Hanzhong biomedical co. LTD | 2020-09-25 |
| VRD as Induction Followed by VR Maintenance in Patients With Newly Diagnosed High Risk Multiple Myeloma (NCT03641456) | Sun Yat-sen University | 2020-09-25 |
| TAS102 in Patients With ER-positive, HER2-negative Advanced Breast Cancer (NCT04489173) | Borstkanker Onderzoek Groep | 2020-09-25 |
| Efficacy and Safety Evaluation of IBI188 in Combination With Demethylating Agents in Treatment of Patients With Acute Myeloid Leukemia (NCT04485052) | Innovent Biologics (Suzhou) Co. Ltd. | 2020-09-25 |
| Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma (NCT04301843) | Giselle Sholler | 2020-09-25 |
| Vardenafil Inhaled for Pulmonary Arterial Hypertension PRN Phase 2B Study (NCT04266197) | Respira Therapeutics, Inc. | 2020-09-25 |
| Combination of Novel Therapies for CKD Comorbid Depression (NCT04422652) | Stony Brook University | 2020-09-24 |
| Randomized Phase II Trial of Salvage Radiotherapy for Prostate Cancer In 4 Weeks v. 2 Weeks (NCT04422132) | Weill Medical College of Cornell University | 2020-09-24 |
| AAV Gene Therapy Study for Subjects with PKU (NCT04480567) | BioMarin Pharmaceutical | 2020-09-24 |
| IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients (NCT04562129) | H. Lee Moffitt Cancer Center and Research Institute | 2020-09-24 |
| GM-CSF Inhalation to Prevent ARDS in COVID-19 Pneumonia (NCT04569877) | University of Giessen | 2020-09-24 |
| A Study of AL2846 Versus Zoledronic Acid in Subjects With Advanced Non-Small Cell Lung Cancer With Bone Metastasis (NCT04325776) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2020-09-24 |
| Clinical Trial to Investigate the Efficacy and Safety of NuSepin® in COVID-19 Pneumonia Patients (NCT04565379) | Shaperon | 2020-09-24 |
| Binge Eating & Birth Control (NCT04278755) | University of North Carolina, Chapel Hill | 2020-09-24 |
| Safety and Efficacy of Anaerobic Cultivated Human Intestinal Microbiome Transplantation in Systemic Sclerosis (ReSScue) (NCT04300426) | Oslo University Hospital | 2020-09-24 |
| FLARE: Favipiravir +/- Lopinavir: A RCT of Early Antivirals (NCT04499677) | University College, London | 2020-09-24 |
| Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS (NCT04493242) | Direct Biologics, LLC | 2020-09-24 |
| A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers (NCT04260802) | Ocellaris Pharma, Inc. | 2020-09-24 |
| Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Sapablursen (Formerly ISIS 702843, IONIS-TMPRSS6-LRx) (NCT04059406) | Ionis Pharmaceuticals, Inc. | 2020-09-24 |
| A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (NCT04566770) | CanSino Biologics Inc. | 2020-09-24 |
| Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome (NCT04540120) | Olatec Therapeutics, Inc. | 2020-09-24 |
| A Trial Looking at the Use of Camostat in People Who Have Tested Positive for Coronavirus (COVID-19) (SPIKE-1) (NCT04455815) | Cancer Research UK | 2020-09-23 |
| QL1604 Plus Chemotherapy in Subjects With Stage IVB, Recurrent, or Metastatic Cervical Cancer (NCT04864782) | Qilu Pharmaceutical Co., Ltd. | 2020-09-23 |
| Omission of Surgery in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti-HER2-based Neoadjuvant Therapy (NCT04578106) | Fundacio Clinic Barcelona | 2020-09-23 |
| Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease (NCT04419025) | Cambridge Health Alliance | 2020-09-23 |
| Camrelizumab in Combination With Apatinib in Patients With Radioactive Iodine-refractory Differentiated Thyroid Cancer (NCT04560127) | Peking Union Medical College Hospital | 2020-09-23 |
| Oral Etoposide Combined With Anlotinib in Advanced Triple Negative Breast Cancer (NCT04452370) | Chinese Academy of Medical Sciences | 2020-09-23 |
| Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration (NCT04339764) | National Eye Institute (NEI) | 2020-09-23 |
| A Study Evaluating the Safety and Efficacy of Venetoclax in Combination With Trastuzumab Emtansine in Patients With Previously Treated HER2-Positive Locally Advanced or Metastatic Breast Cancer (NCT04298918) | Hoffmann-La Roche | 2020-09-23 |
| Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer (NCT04333537) | NRG Oncology | 2020-09-23 |
| Pharmacological Modulation of Hippocampal Activity in Psychosis 2 (NCT04559529) | Vanderbilt University Medical Center | 2020-09-23 |
| Study to Assess Effect of Oral Venetoclax Tablet in Combination With Oral Ibrutinib Capsule on Best Overall Response of Complete Response in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma (NCT04477486) | AbbVie | 2020-09-23 |
| Therapeutic Effects of Traditional Chinese Medicine in Topical Use on Upper Extremities Fracture (NCT04593849) | YUAN-CHIEH YEH | 2020-09-23 |
| Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors (NCT04557449) | Pfizer | 2020-09-23 |
| The Effects of CBD Isolate on Menstrual-Related Symptoms (NCT05679830) | Canopy Growth Corporation | 2020-09-23 |